Cwm, LLC Immunity Bio, Inc. Transaction History
Cwm, LLC
- $33.3 Billion
- Q3 2025
A detailed history of Cwm, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Cwm, LLC holds 44,259 shares of IBRX stock, worth $108,434. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,259
Previous 48,715
9.15%
Holding current value
$108,434
Previous $129,000
15.5%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding IBRX
# of Institutions
277Shares Held
121MCall Options Held
2.49MPut Options Held
3.14M-
Vanguard Group Inc Valley Forge, PA21.8MShares$53.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$28 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC8.76MShares$21.5 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.76MShares$19 Million0.36% of portfolio
-
Jane Street Group, LLC New York, NY7.72MShares$18.9 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $981M
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...